Skip to main content
U.S. flag

An official website of the United States government

A Multivalent mRNA-lipid nanoparticle vaccine containing eight hemagglutinin antigens elicits broad neutralizing antibody responses and partially protects against influenza A challenge in swine

Published by Agricultural Research Service | Department of Agriculture | Catalog Last Checked: August 03, 2026 at 05:01 PM | Dataset Last Updated: June 08, 2026
Influenza A virus is an important respiratory pathogen in swine, and zoonotic transmission of swine strains to humans is a risk. Control strategies against IAV in North American swine herds rely heavily on biosecurity measures and vaccination. However, the antigenic diversity of IAV circulating in swine challenges current vaccination programs, and there is a need for broadly protective vaccines or platforms that can rapidly update components to reflect the circulating diversity. mRNA-LNP vaccines have emerged as promising alternatives, offering simultaneous delivery of multiple antigens, rapid development, scalable manufacturing, and potent immunogenicity. In this study, we assessed the immunogenicity and protective capacity of monovalent and multivalent mRNA-LNP vaccines encoding eight representative IAV HA clade antigens. To our knowledge, this is the first study to objectively select multiple representative endemic swine IAV strains by quantifying genetic diversity within the phylogeny and to apply this selection to rationally design and evaluate a multivalent HA mRNA-based influenza vaccine in the swine model.

Resources

5 resources available

Find Related Datasets

Search by Tags

Click any tag below to search for similar datasets

data.gov

An official website of the GSA's Technology Transformation Services

Looking for U.S. government information and services?
Visit USA.gov